Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
The relationship between pre-treatment albumin and overall survival at 12 weeks, 6 months and 1 year in patients with NSCLC treated with first-line targeted therapy or immunotherapy-based therapy.
| Albumin | Patients | Survival at 12 weeks | Survival at 6 months | Survival at 1 year | |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | ||
| Targeted Therapy | ≥35g/L | 101 (64) | 99 (98) | 86 (85) | 60 (59) |
| <35g/L | 58 (36) | 47 (81) | 40 (69) | 28 (48) | |
| Immunotherapy | ≥35g/L | 120 (52) | 110 (92) | 99 (83) | 59 (49) |
| <35g/L | 110 (48) | 79 (72) | 60 (55) | 27 (25) |
